baber/WOPTO huggingface dataset:
Patent WO-2007027157-A1 (WO)
Title: Method of deriving progenitor cell line
Inventor: LIM SAI KIANG
IPC: G01N33/50
Filed: 2006-08-15
Abstract: We disclose a method comprising: (a) providing an embryonic stem (ES) cell; and (b) establishing a progenitor cell line from the embryonic stem cell; in which the progenitor cell line is selected based on its ability to self-renew. Preferably, the method selects against somatic cells based on their inability to self-renew. Preferably, the progenitor cell line is derived or established in the absence of co-culture, preferably in the absence of feeder cells, which preferably selects against embryonic stem cells. Optionally, the method comprises (d) deriving a differentiated cell from the progenitor cell line.
Patent SG-138472-A1 (SG)
Title: System and method for automated focus measuring of a lithography tool
Inventor: LYONS JOSEPH H
IPC: G03F7/22
Filed: 2003-06-24
Abstract: A system and method are used to calibrate a focus portion of an exposure section of a lithography tool. A wafer is exposed so that a resulted or formed patterned image is tilted with respect to the wafer. The tilting can be imposed based on controlling a wafer stage to tilt the wafer or a reticle stage to tilt the reticle. The wafer is developed. Characteristics of the tilted patterned image are measured with a portion of the lithography tool to determine focus parameters of an exposure system. The portion can bean alignment system. The measuring step can measure band width and/or band location of the tilted patterned image. Sometimes, more than one patterned image is formed on the wafer, then the measuring step can measure distance between bands and shifting of the bands with respect to a central axis of the wafer. The focus parameters can be focus tilt errors and/or focus offset. The focus parameters are used to perform calibration. Calibration is done by either automatically or manually entering compensation values for the measured focus parameters into the lithography tool.
Patent WO-2008030200-A1 (WO)
Title: Préhenseur doté de trois mâchoires formant deux pinces
Inventor: WANG HONGGANG
IPC: B25J15/10
Filed: 2007-09-07
Abstract: L'invention concerne un système de transport d'une ponteuse pour le transport d'une bande depuis un chargeur d'entrée vers la zone de soudage et vers un chargeur de sortie qui comprend deux préhenseurs. Le premier préhenseur est un préhenseur de traction prévu pour tirer la bande vers l'extérieur du chargeur d'entrée et la transporter vers la zone de soudage. Le deuxième préhenseur et un préhenseur éjecteur prévu pour transporter la bande depuis la zone de soudage vers le chargeur de sortie et la pousser dans le chargeur de sortie. Les préhenseurs comprennent trois leviers (16, 17, 18) portés par un axe commun, un moteur unique et un moyen pour transformer la rotation du moteur en rotations des trois leviers.
Patent SG-134234-A1 (SG)
Title: System and method for managing call routing in a network environment including ims
Inventor: BUCKLEY ADRIAN
IPC: H04W36/00
Filed: 2007-01-04
Abstract: A network node and a method for call routing by a network node disposed in a network environment including a circuit-switched (CS) network and an Internet Protocol (IP) multimedia subsystem (IMS) network, the method comprising: receiving a message for setting up a call; allocating_an IP Multimedia Routing Number (IMRN) for purposes of setting up the call; sending the IMRN to at least one of a user equipment (UE) device and a mobile switching center (MSC); receiving a subsequent message containing the IMRN; and setting up the call using an original called number that maps to the IMRN, wherein the setting up of the call comprises inserting a CallerID by said IMS.
Patent SG-137830-A1 (SG)
Title: End structural assembly of a rail car body
Inventor: CAMPUS EMIGLIANO
Filed: 2007-05-30
Abstract: This structural assembly (12) is of the type intended to be fixed to a longitudinal end of a rail car body (2) comprising a chassis (4), a roof (6) and lateral faces (8, 10) forming a tubular cell, in order to articulate the body (2) to a body of another adjacent car and to transfer the load of the body (2) to a body support bogie that is common to that other car. In accordance with an aspect of the invention, it comprises a lower cross-member (16) having a central portion (34) and two lateral portions (36), the central portion being provided in order to carry a member (24) for articulating the body to a body of another car, and each lateral portion being suitable for being supported on suspension devices for the body on a bogie.
Patent SG-143121-A1 (SG)
Title: Magnetic recording medium, magnetic recording apparatus, and method of manufacturing magnetic recording medium
Inventor: GOUKE TAKASHI
Filed: 2007-09-25
Abstract: MAGNETIC RECORDING MEDIUM, MAGNETIC RECORDING APPARATUS, AND METHOD OF MANUFACTURING MAGNETIC RECORDING MEDIUM This invention relates to a magnetic recording medium that magnetically records information, and the like. The magnetic recording medium enhances write reception performance by reducing the distance between a recording layer and a backing layer while maintaining low noise performance. The magnetic recording medium has a non-magnetic substrate, a backing layer formed on the non-magnetic substrate, an underlayer formed on thebacking layer, an intermediate layer formed on the underlayer, and a recording layer which is formed on the intermediate layer and which is a perpendicular magnetic anisotropy. The intermediate layer includes two or more layers which are formed as film layers such that anupper layer of the two or more layers has a thicker film thickness and a higher gas pressure at which the layer is formed in comparison to a layer under the upper layer.
Patent SG-145769-A1 (SG)
Title: Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
Inventor: MARTIS LEO
IPC: C12Q1/37
Filed: 2005-02-18
Abstract: METHODS AND COMPOSITIONS FOR DETECTION OF MICROBIAL CONTAMINANTS IN PERITONEAL DIALYSIS SOLUTIONS Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. A novel cause of aseptic peritonitis is provided--aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution. Peptidoglycan is a major component of a gram positive bacterial cell wall and thus can serve as a marker for gram positive bacteria. In this regard, testing for peptidoglycans can be utilized to effectively prevent peritonitis in patients that use the peritoneal dialysis solutions, such as peritoneal dialysis solutions that contain a glucose polymer including an icodextrin and the like.
Patent SG-161109-A1 (SG)
Title: Water and air treatment
Inventor: DAVID LIANG TEE
Filed: 2008-10-15
Abstract: The present invention relates to new methods to control the speciation as well as the proportion of active radicals generated from a dielectric barrier discharge (DBD) system to allow for more efficient oxidation/degradation of organic pollutants and disinfection/destruction of biological contaminants. It also includes a method for treating air and water, the method comprising introducing radicals generated from a dielectric barrier discharge into a reactor containing the air or water to be treated. (Figure 1)
Patent SG-151320-A1 (SG)
Title: Absorbent member for absorbent articles comprising swellable polymers of high permeability which are capable of forming hydrogels
Inventor: BORGMANN CAROLIN MICHAELA
IPC: C08L101/00
Filed: 2005-03-28
Abstract: ABSORBENT MEMBER FOR ABSORBENT ARTICLES COMPRISING SWELLABLE POLYMERS OF HIGH PERMEABILITY WHICH ARE CAPABLE OF FORMING HYDROGELS The present invention relates to absorbent members in absorbent cores for absorbent articles, which are intended to receive and retain bodily discharges such as urine. Such articles are disposable hygiene articles like baby diapers, training pants, adult incontinence articles, feminine care articles and the like. The improvement essentially is based on the recognition that replacing most or all of the cushioning fibrous absorbent material in an absorbent core by a liquid storage material capable of retaining liquid while maintaining or improving acquisition behavior is desirable as the reduction in cushioning is more than compensated by the gain in comfort. The absorbent core of the absorbent member comprises a swellable hydrogel-forming polymer comprising in combination at least one hydrophilic polymer with dendritic structure and at least one water-insoluble phosphate.
Patent SG-164326-A1 (SG)
Title: Washing machine
Inventor: YAZAWA RYUTA
Filed: 2010-02-08
Abstract: A includes a washing and dewatering tub, a rotary vane provided at an inner bottom section of the washing and dewatering tub, a driving unit for rotating the washing and dewatering tub and the rotary vane, and a controller, wherein the controller controls the rotation of the rotary vane by reversing a clockwise rotation of the rotary vane to an anticlockwise rotation and. vice versa so that number of rotations of the rotary vane in the clockwise rotation and number of rotations of the rotary vane in the anticlockwise rotation are different to each other. Accordingly, laundry during wash can be moved around in the tub through upward and downward movements and reversal of the upward and downward movements. The washing machine can lessen the likelihood that part of detergent is left undissolved and the laundry may not be evenly washed, thereby making improvements in its water saving capacity and washing performance.
Patent SG-173246-A1 (SG)
Title: Medical adhesive tape
Inventor: HUANG WEN-HSI
Filed: 2010-07-29
Abstract: MEDICAL ADHESIVE TAPEAbstractA medical adhesive tape comprises a base fabric layer, amedicament layer and a release paper. The base fabric layer has apattern layer on the surface that contains a selected pattern or textformed by printing, embroidering or embossing. The base fabriclayer may also be attached by a bonded layer on the surface that canbe bonded repeatedly. The bonded layer has a pattern layer on thesurface that contains a selected pattern or text formed by printing,embroidering or embossing. The pattern or text aims to provideidentification effect.Figure 2
Patent SG-165344-A1 (SG)
Title: Method for treating vasculitis
Inventor: BRUNETTA PAUL G
Filed: 2005-09-28
Abstract: A method of treating anti-neutrophil cytoplasmic antibodies-associated vasculitis (ANCA-associated vasculitis) in a patient eligible for treatment is provided involving administering an antagonist that binds to a B-cell surface marker, such as CD20 antibody, to the patient in a dose of about 400 mg to 1.3 grams at a frequency of one to three doses within a period of about one month. Another method of treating ANCA-associated vasculitis in a subject eligible for treatment is provided involving administering an effective amount of an antibody that binds to a B-cell surface marker to the subject to provide an initial exposure and a subsequent exposure to the antibody within certain dosing regimens. Further provided are articles of manufacture useful for such methods. Figure No. 8
Patent SG-171756-A1 (SG)
Title: Device for floating production of lng and method for converting a lng-carrier to such a device
Inventor: SANNES LARS
IPC: B63B83/00
Filed: 2009-10-28
Abstract: The invention relates to a device for floating production of LNG. The device comprises a LNG carrier comprising a ship hull (12) and at least one spherical LNG storage tank (13) for storing LNG, a projecting hull structure (16) fixed to the ship hull (12), a LNG production system (17) for converting natural gas to LNG, where the LNG production system is arranged in the projecting hull structure (16) and means for transferring LNG from the LNG production system (17) to the at lest one spherical LNG storage tank (13). The invention also relates to a method for converting an LNG-carrier to a device for floating production of LNG.
Patent SG-172254-A1 (SG)
Title: Covalent diabodies and uses thereof
Inventor: JOHNSON LESLIE S
Filed: 2009-12-17
Abstract: The present invention is directed to diabody molecules and uses thereof in the treatment of a variety of diseases and disorders, including immunological disorders, infectious disease, intoxication and cancers. The diabody molecules of the invention comprise two polypeptide chains that associate to form at least two epitope binding sites, which may recognize the same or different epitopes on the same or differing antigens. Additionally, the antigens may be from the same or different molecules. The individual polypeptide chains of the diabody molecule may be covalently bound through non-peptide bond covalent bonds, such as, but not limited to, disulfide bonding of cysteine residues located within each polypeptide chain. In particular embodiments, the diabody molecules of the present invention further comprise an Fc region, which allows antibody- like functionality to engineered into the molecule.
Patent SG-180075-A1 (SG)
Title: Method for molecular bonding of silicon and glass susbtrates
Inventor: SEBASTIEN KERDILES
Filed: 2011-08-24
Abstract: OF THE DISCLOSUREThe present invention concerns a method for bonding a first substrate (1a) having a first surface (2a) to a second substrate (1 b) having a second surface (2b), characterized in that it comprises the steps of:5 - holding the first substrate (1a) by at least two support points (Si, S2),positioning the first substrate (la) and the second substrate (lb) so that the first surface (2a) and the second surface (2b) face each other,deforming the first substrate (la) by applying between at least one pressure point (P1) and the two support points (51, S2), a strain (F) toward the second 10 substrate (lb),- bringing the deformed first surface (2a) and the second surface (2b) into contact,progressively releasing the strain (F). Figure 6b
Patent SG-188681-A1 (SG)
Title: Building board and building production method
Inventor: TAKAHIRO YAMAGUCHI
Filed: 2011-09-14
Abstract: OF THE DISCLOSURE Provided are a building board that exhibits high weathering performance and that has an inkjet coating film unaffected by the drying state of a base coating film, and a coating method for the building board. In the building board, a base coating film, an inkjet coating film and a clear coating film are sequentially formed on a surface of an inorganic board; the inkjet coating film is a cured product of a UV-curable ink; and the clear coating film contains 0.1 to 10.0 wt% of a light stabilizer and/or ultraviolet absorbent. A method of producing a building board includes the steps of:implementing base coating onto a surface of an inorganic board; performing inkjet coating by coating a UV-curable ink onto the surface of the base-coated inorganic board and curing the UV-curable ink through irradiation of UV rays; and performing clear coating by applying a clear coating material containing 0.1 to 10.0 wt%, on solids basis, of a light stabilizer and/or ultraviolet absorbent, onto the surface of the inkjet-coated inorganic board. NO FIGURE
Patent SG-176534-A1 (SG)
Title: Plug valve indicator
Inventor: WITKOWSKI BRIAN C
Filed: 2010-06-03
Abstract: A valve has a body having a rotatable valve element. A drive mechanism has a drive input member and a drive output member that are coupled to the valve element for rotating the valve element. A shear member is operatively located within the drive mechanism between the drive input member and the drive output member for shearing in the event the force to rotate the valve element is excessive. The valve has indicia indicating open and closed positions for the valve element An indicator is mounted to output drive member to properly align with the indicia regardless whether the shear member has sheared or not.
Patent SG-177951-A1 (SG)
Title: System, device and method for dermal imaging
Inventor: BANDIC JADRAN
Filed: 2008-01-07
Abstract: SYSTEM, DEVICE AND METHOD FOR DERMAL IMAGINGAbstractIn embodiments of the present invention, systems and methods of a non-invasive imaging device may comprise an illumination source comprising an incident light source to direct light upon skin, and a detector for detecting the degree of polarization of light reflected from the skin. A system and method of determining a skin state may be based on an aspect of the polarization of the reflected light.Figure 1
Patent SG-184388-A1 (SG)
Title: Pharmaceutical formulations for the treatment of overactive bladder
Inventor: PABORJI MEHDI
Filed: 2011-04-01
Abstract: Disclosed herein are pharmaceutical compositions comprising a plurality of first beads each comprising: a core; a first layer comprising pilocarpine or a pharmaceutically acceptable salt thereof; and a second layer comprising a first polymer. Also disclosed are pharmaceutical compositions comprising a plurality of second beads each comprising: a core; and a first layer comprising tolterodine or a pharmaceutically acceptable salt thereof. Further disclosed are pharmaceutical formulations comprising: a) a plurality of the first beads; b) a plurality of the second beads; or c) a plurality of the first beads and a plurality of the second beads.
Patent SG-186200-A1 (SG)
Title: Injectable flowable composition comprising buprenorphine
Inventor: NORTON RICHARD L
Filed: 2011-06-06
Abstract: The present invention is directed to a buprenorphine sustained release delivery system capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 14 days to about 3 months. The buprenorphine sustained release delivery system includes a flowable composition and a solid implant for the sustained release of buprenorphine, a metabolite, or a prodrug thereof. The implant is produced from the flowable composition. The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis.
Patent WO-2013133772-A1 (WO)
Title: Procédé intégré de spectrométrie de masse par chromatographie en phase liquide à ultra-performance couplée à l'extraction en phase solide pour le profilage de métabolites du dxp et diagnostic de système de voie du dxp
Inventor: TOO HENG PHON
IPC: G01N30/08
Filed: 2013-03-08
Abstract: L'invention concerne un procédé permettant d'extraire au moins un premier métabolite de voie du 1-désoxy-D-xylulose-5-phosphate (DXP) et au moins un second métabolite de voie DXP à partir d'un échantillon et de détecter le(s) premier(s) et le(s) second(s) métabolite(s) de voie du DXP dans l'échantillon simultanément. L'invention concerne également un procédé permettant d'identifier un modulateur, tel qu'un inhibiteur, d'une enzyme dans la voie du DXP à des fins de découvertes de médicaments.
Patent SG-188839-A1 (SG)
Title: Multi-mode communication ingestible event markers and systems, and methods of using the same
Inventor: ROBERTSON TIMOTHY
Filed: 2009-03-05
Abstract: OF THE DISCLOSURE 5 Aspects of the invention include multi-mode communication ingestible eventmarker devices. Ingestible event marker devices of the invention include an ingestible component comprising a conductive communication module and at least one additional non-conductive communication module. The non-conductive communication module may be integrated with the ingestible component or at least a portion or all of the non 10 conductive communication module may be associated with a packaging component of the ingestible event marker device. Additional aspects of the invention include systems thatinclude the devices and one or more receivers, as well as methods of using the same. Fig. 1A & 1B
Patent SG-188626-A1 (SG)
Title: Process for concentrating omega-3 fatty acids
Inventor: BREIVIK HARALD
Filed: 2011-09-23
Abstract: The present disclosure relates generally to processes for concentrating omega-3 fatty acids from a fatty acid oil mixture with an aqueous silver salt, such as an aqueous AgNO3 solution.
Patent SG-191983-A1 (SG)
Title: Light therapy system including spectacle frames and contact lenses
Inventor: PUGH RANDALL B
Filed: 2012-02-02
Abstract: The present invention provides for eyeglasses used together with contact lenses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. The eyeglass lenses or frames project light into complimentary contact lenses which refract, diffract or reflect light into the wearer's eyes.
Patent SG-194078-A1 (SG)
Title: Intraocular lens design method and intraocular lens
Inventor: SUZUKI TAKAYOSHI
Filed: 2012-04-02
Abstract: INTRAOCULAR LENS DESIGN METHOD LI INTRAOCULAR LENSProvided is ate clique which, in the design of intraocular lenses, simplifies design work and makes it possible for aberration of the entire eyeball to more precisely match a target value when the designed intraocular lens is inserted into a patient's eye. Thistraocular lens design method involves deriving an intraocular lens aberration target: value from the aberration of the cornea and anterior chamber and a sit value- the total eyeball aberration (3102) , and determining an intraocular lens shape such that the at least the aberration of the intraocular lens coincides with the target-. value (S103-S107) The intraocular lens aberration is set to an intraocular lens aberration for which prescribed convergent light is incident to the intraocular lens (5104) .
Patent SG-194678-A1 (SG)
Title: Hydrogenated petroleum resin pellet production method
Inventor: KASHIMA MAKOTO
Filed: 2012-05-31
Abstract: After a cyclopentadiene compound and a vinyl aromatic compound are thermally polymerized in a polymerizing portion (2), the obtained copolymer is subjected to hydrogenation reaction in a hydrogenating portion (3). After most of a hydrogenation 5 solvent is separated by a solvent evaporation tank (41) from the hydrogenated product obtained in the hydrogenating portion (3), an additive separately prepared by dissolving an antioxidant is added in an adding portion (43). While the hydrogenation solvent is a naphthenic solvent, the additive is prepared by dissolving the antioxidant in an aromatic additive solvent having the same carbon atoms as those of the hydrogenation solvent. A 10 low-molecular-weight component as well as the remaining hydrogenation solution and the additive solvent are separated by a thin-film evaporator (42) from the hydrogenated product added with the additive. The obtained molten resin is pelletized in a pelletizing portion (5) to produce hydrogenated petroleum resin pellets. Time for uniformly blending the antioxidant can be shortened.
Patent SG-194728-A1 (SG)
Title: Inhibitors of bruton's tyrosine kinase
Inventor: BILLEDEAU ROLAND J
Filed: 2012-05-14
Abstract: This application discloses compounds according to generic Formula I: wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formula I and at least one carrier, diluent or excipient.